Close Menu
    What's Hot

    ReAssure Staff Pension Scheme Completes Bulk Purchase Annuity Transaction With Standard Life

    July 27, 2026

    Miller Retirement Benefits Scheme Completes Bulk Purchase Annuity Buy-In With M&G

    July 27, 2026

    Credit Commercial de France Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

    July 23, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      Pacific Life Re Appoints Florence Durousseau as Head of Capital Solutions, Europe

      June 15, 2026

      Third Block Reinsurance Deal With Tokio Marine & Nichido Life for Pacific Life Re

      June 10, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      ReAssure Staff Pension Scheme Completes Bulk Purchase Annuity Transaction With Standard Life

      July 27, 2026

      Miller Retirement Benefits Scheme Completes Bulk Purchase Annuity Buy-In With M&G

      July 27, 2026

      Credit Commercial de France Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

      July 23, 2026

      Smiths Industries Pension Scheme Completes Bulk Purchase Annuity Buy-In With M&G

      July 23, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026
      Litigation

      Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

      July 22, 2026

      South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

      July 22, 2026

      Optimism for Stronger Second Half in the Life Settlement Tertiary Market

      July 8, 2026

      US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

      July 8, 2026

      ReAssure Staff Pension Scheme Completes Bulk Purchase Annuity Transaction With Standard Life

      July 27, 2026

      Miller Retirement Benefits Scheme Completes Bulk Purchase Annuity Buy-In With M&G

      July 27, 2026

      Credit Commercial de France Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

      July 23, 2026

      Smiths Industries Pension Scheme Completes Bulk Purchase Annuity Buy-In With M&G

      July 23, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    UK Closed Life Funds – A Secret Returns Goldmine?

    Life Insurance July 12, 2023By Roger Lawrence
    Share
    Twitter LinkedIn Email

    More than 200 years ago, Equitable Life, the now defunct UK mutual life insurer, realised that they were making excess profits and started distributing them to policyholders via reductions in the following years’ premium. This profit distribution evolved into making annual increases to the sums insured; the next evolutionary iteration was to deliberately load premiums to allow for scope to intentionally generate “profits” by diverting the additional margin into riskier but hopefully more profitable assets. Finally, insurers were doing so well, especially from a buoyant stock market, they began adding a further “terminal” bonus to pay-outs funded from the excess returns they achieved that had not already been distributed through annual additions.

    This style of product, so-called “with-profits”, became a commonplace savings vehicle in the UK and spread around much of the Commonwealth. UK Prime Minister Margaret Thatcher’s private personal pensions revolution in the mid-1980s created yet more demand for this form of hybrid investment – guarantees but with equity driven upside – as did a tax relief on mortgage interest in 1983 that created a boom in life assurance-based saving.

    However, with-profits was not a perfect panacea in all economic climates. When inflation, and consequently interest rates, began to fall, the cost of providing a guarantee in nominal terms became increasingly expensive. It also got regulators twitchy because high guarantees mean an increased risk of insolvency. So, ironically, it was the failure of Equitable Life in the early 2000s that led to a rapid tightening of solvency reserving. That, the cost of guarantees impairing returns, and the cancellation of tax relief on mortgage interest, all turned against with-profits and by 2004, large funds began closing and consolidating. Today, there are only a handful of funds still writing new business – and those that are, do so at much reduced levels.

    Many hands were wrung over the plight of these so-called “zombie” or “orphan” funds – closed to new business and in a state of run-off that nobody loved and nobody seemed to want to manage. Would policyholders’ expectations be curtailed by over-cautious investment strategies?

    Some funds were undoubtedly in a terrible condition, and no amount of nursing would fully turn them around but, following the end of the dotcom bubble in 2004, and with careful guarantee management, a lot of these funds have not only returned to good health once again, but are now flush with surplus. Some funds may have been required to distribute the surplus to shareholders but most of them are contractually required to distribute the majority of the surplus to policyholders.

    There was concern, especially amongst regulators, that a huge iniquity would develop: the insurer holding back the surplus for far too long, until just a handful of policyholders would be eligible for a massive payout – the so-called tontine effect. The regulator urged insurers to pay out as much surplus as they could, as soon as possible, to ensure a fairer pay-out to all policyholders that were still in the fund at closure. This has led to the build-up of some substantial additions to policyholders’ basic accrued asset shares.

    The method and style of distribution was left to insurers and each of the many approaches favours certain policyholders such as long-stayers or those with distant maturity dates. Two of the main methods are to either bulk up the annual investment returns through an annual addition, or to simply divide all the surplus at any time amongst all policyholders and apply an equal share to all policies that become a claim (the so-called “terminal bonus addition”).

    Much of this started in or around 2010 and the purchaser of a second-hand policy at that time has achieved a supra-return through these additions. A 30% terminal bonus addition emerging equates to roughly 3% per annum being added to underlying returns over a 10-year period. The table below shows the returns for the past 12 years of two funds which have chosen to go through the annual additions route:

    Figure 2: Progression of Enhancements to Basic Asset Shares (8 Selected Companies), 2014 – 2022

    Life Office

    2014

    2016

    2018

    2020

    2022

    Per annum equivalent

    Colonial Mutual

    0.0%

    0.0%

    1.0%

    20.0%

    25.0%

    2.8%

    Friends Provident

    0.0%

    0.0%

    8.0%

    12.0%

    10.0%

    1.2%

    National Mutual of Australasia

    75.0%

    85.0%

    90.0%

    90.0%

    105.0%

    2.0%

    Pearl Assurance*

    24.5%

    28.8%

    34.6%

    36.2%

    34.1%

    0.9%

    Royal Life Insurance*

    17.0%

    33.9%

    37.0%

    56.4%

    57.5%

    3.8%

    Scottish Mutual

    16.8%

    20.0%

    35.4%

    50.4%

    44.3%

    2.7%

    Scottish Provident*

    24.3%

    33.5%

    44.9%

    50.0%

    49.9%

    2.4%

    Winterthur Life

    0.0%

    0.0%

    1.0%

    20.0%

    25.0%

    2.8%

    *Adjusted for enhanced annual additions also made.

    Source: W L Consulting (collation from life office’s own data)

    Compounding the annual performance of these funds leads to some substantial “free” additions from surplus of 63% and 25% of policy assets, respectively. This is on top of the returns achieved on the underlying assets, which are broadly comparable with other mixed asset funds and give total returns of more than 7% or 8% per annum in an era when base rates were nearly zero.

    Figure 2 below shows the equivalent additional return represented by the increase in the uplift in the terminal bonus addition between 2014 and 2022. National Mutual of Australasia had, for example, been enhancing pay-outs well before 2014 but by lower amounts than in 2022 and the 2%pa annual return uplift is equivalent to the terminal bonus addition rising from 75% to 105% only.

    Figure 2: Progression of Enhancements to Basic Asset Shares (8 Selected Companies), 2014 – 2022

    Life Office

    2014

    2016

    2018

    2020

    2022

    Per annum equivalent

    Colonial Mutual

    0.0%

    0.0%

    1.0%

    20.0%

    25.0%

    2.8%

    Friends Provident

    0.0%

    0.0%

    8.0%

    12.0%

    10.0%

    1.2%

    National Mutual of Australasia

    75.0%

    85.0%

    90.0%

    90.0%

    105.0%

    2.0%

    Pearl Assurance*

    24.5%

    28.8%

    34.6%

    36.2%

    34.1%

    0.9%

    Royal Life Insurance*

    17.0%

    33.9%

    37.0%

    56.4%

    57.5%

    3.8%

    Scottish Mutual

    16.8%

    20.0%

    35.4%

    50.4%

    44.3%

    2.7%

    Scottish Provident*

    24.3%

    33.5%

    44.9%

    50.0%

    49.9%

    2.4%

    Winterthur Life

    0.0%

    0.0%

    1.0%

    20.0%

    25.0%

    2.8%

    *Adjusted for enhanced annual additions also made.

    Source: W L Consulting (collation from life office’s own data)

    Is this of benefit to the ILS investor? Well, yes and no. Clearly, the tontine effect much talked about in the mid-2000s seems to be occurring, albeit much diminished by regulatory guidance. Access to surpluses is also significantly curtailed because of the decline to near zero of policies qualifying for these rewards. There do remain opportunities, but very much on a cottage industry level, unlikely to be of interest to the institutional scale investor. However, it is worth bearing in mind that there may be other pockets of untapped reserves that emerge in other markets, just as they have in the UK.

    Roger Lawrence is Managing Director at WL Consulting


    Any views expressed in this article are those of the author(s) and do not necessarily reflect the views of Life Risk News or its publisher, the European Life Settlement Association.

    2023 - July Commentary Volume 2 Issue 7 - July 2023
    Share. Twitter LinkedIn Email

    Related Posts

    From Policy Ambition to Operational Reality: Building the Foundations of the UK’s Next Pensions Era

    June 24, 2026By Peter Roos

    Shaping the Future of Health Insurance Through Innovation and Analytics

    June 10, 2026By Jessica Plewes and Lisa Balboa

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026By Dr. Jyotsna Kamble

    Better Mortality Analytics Will Unlock the Next Phase of Life Settlement Growth

    April 9, 2026By Liam Bodemeaid
    Latest Issue

    Optimism for Stronger Second Half in the Life Settlement Tertiary Market

    July 8, 2026

    Organ Transplant Improvements Test Life Expectancy Assessment Models

    July 8, 2026

    US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

    July 8, 2026

    Passage of UK Pension Schemes Act Seen Boosting Size of DB Superfund Market

    June 24, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.